Biogen downgraded to Hold from Buy at Stifel
February 21, 2019 at 08:47 AM EST
Stifel analyst Paul Matteis downgraded Biogen to Hold from Buy and lowered his price target for the shares to $346 from $397.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|